The Biotech industry is up 3.5% in the last week, with Medicenna Therapeutics up 22%. Meanwhile, Spectral Medical actually underperformed within the industry, shrinking 6.4% in the last week. However, the industry is down 35% over the past year. Earnings are forecast to grow by 36% annually.
Has the Canadian Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 08 May 2024 | CA$960.9m | CA$78.8m | -CA$301,771,305.58 | 322.5x | -3.2x | 12.2x |
Fri, 05 Apr 2024 | CA$988.8m | CA$88.1m | -CA$279,252,229.47 | 10.2x | -3.5x | 11.2x |
Sun, 03 Mar 2024 | CA$1.2b | CA$91.6m | -CA$325,002,295.97 | 11.5x | -3.6x | 12.7x |
Tue, 30 Jan 2024 | CA$3.6b | CA$87.8m | -CA$515,087,954.00 | 6.9x | -6.9x | 40.6x |
Thu, 28 Dec 2023 | CA$3.6b | CA$86.1m | -CA$521,349,756.00 | 6.9x | -6.9x | 41.9x |
Sat, 25 Nov 2023 | CA$3.9b | CA$86.4m | -CA$546,998,271.00 | 5.9x | -7.1x | 44.8x |
Mon, 23 Oct 2023 | CA$3.8b | CA$89.0m | -CA$532,672,654.00 | 5.2x | -7x | 42.2x |
Wed, 20 Sep 2023 | CA$3.9b | CA$88.8m | -CA$516,884,583.00 | 5.7x | -7.5x | 44x |
Fri, 18 Aug 2023 | CA$4.0b | CA$87.3m | -CA$524,549,109.00 | 6.7x | -7.6x | 45.5x |
Sun, 16 Jul 2023 | CA$4.1b | CA$81.5m | -CA$516,636,148.00 | 14.2x | -7.9x | 49.9x |
Tue, 13 Jun 2023 | CA$3.9b | CA$86.5m | -CA$548,845,831.00 | 12x | -7.1x | 45.1x |
Thu, 11 May 2023 | CA$3.8b | CA$82.3m | -CA$584,445,054.00 | 12.2x | -6.5x | 45.9x |
Sat, 08 Apr 2023 | CA$2.3b | CA$84.3m | -CA$594,792,725.00 | 8.9x | -3.9x | 27.6x |
Mon, 06 Mar 2023 | CA$2.7b | CA$90.4m | -CA$591,355,112.00 | 8.1x | -4.6x | 30.2x |
Wed, 01 Feb 2023 | CA$3.0b | CA$86.4m | -CA$523,065,597.00 | 13.1x | -5.6x | 34.2x |
Fri, 30 Dec 2022 | CA$3.0b | CA$87.6m | -CA$533,476,085.00 | 11.3x | -5.5x | 33.7x |
Sun, 27 Nov 2022 | CA$3.1b | CA$88.4m | -CA$577,679,261.00 | 7.7x | -5.4x | 35.2x |
Tue, 25 Oct 2022 | CA$3.1b | CA$86.1m | -CA$551,596,803.00 | 15.1x | -5.6x | 35.8x |
Thu, 22 Sep 2022 | CA$3.3b | CA$85.2m | -CA$542,170,558.00 | 13.5x | -6.2x | 39.2x |
Sat, 20 Aug 2022 | CA$3.5b | CA$85.3m | -CA$530,501,715.00 | 17.5x | -6.5x | 40.5x |
Mon, 18 Jul 2022 | CA$3.1b | CA$87.4m | -CA$568,583,553.00 | 10.3x | -5.5x | 36x |
Wed, 15 Jun 2022 | CA$3.0b | CA$181.3m | -CA$598,365,218.00 | 12.9x | -5x | 16.4x |
Fri, 13 May 2022 | CA$3.0b | CA$182.4m | -CA$472,146,438.00 | 12.4x | -6.3x | 16.4x |
Sun, 10 Apr 2022 | CA$3.6b | CA$170.9m | -CA$482,871,906.00 | 14.8x | -7.5x | 21.1x |
Tue, 08 Mar 2022 | CA$3.1b | CA$170.1m | -CA$472,355,288.00 | 15.7x | -6.7x | 18.5x |
Thu, 03 Feb 2022 | CA$3.5b | CA$167.6m | -CA$446,157,706.00 | 18.5x | -7.8x | 20.8x |
Sat, 01 Jan 2022 | CA$3.7b | CA$167.3m | -CA$432,324,397.00 | 21.7x | -8.6x | 22.3x |
Mon, 29 Nov 2021 | CA$5.8b | CA$172.7m | -CA$475,661,266.00 | 5.1x | -12.2x | 33.6x |
Wed, 27 Oct 2021 | CA$8.0b | CA$244.5m | -CA$609,382,014.00 | 7.4x | -13.1x | 32.6x |
Fri, 24 Sep 2021 | CA$8.1b | CA$242.1m | -CA$608,454,234.00 | 7.1x | -13.4x | 33.6x |
Sun, 22 Aug 2021 | CA$3.4b | CA$161.7m | -CA$473,092,915.08 | 28x | -7.2x | 21.1x |
Fri, 09 Jul 2021 | CA$4.1b | CA$161.7m | -CA$473,575,158.08 | 27.5x | -8.7x | 25.6x |
-8.3x
How does Canadian Biotech compare with similar industries?
CA Market | 2.53% | |
Healthcare | -12.82% | |
Biotech | 3.50% | |
Biotech | 3.50% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
MDNA Medicenna Therapeutics | CA$2.82 | 21.6% +CA$49.3m | 176.5% | PB11.3x | |
EPRX Eupraxia Pharmaceuticals | CA$3.99 | 8.1% +CA$10.7m | -43.0% | PB46.7x | |
DTC Defence Therapeutics | CA$1.40 | 14.8% +CA$8.2m | -51.7% | PE-4.7x | |
ONC Oncolytics Biotech | CA$1.62 | 5.9% +CA$6.8m | -26.0% | PB4.4x | |
ACOG Alpha Cognition | CA$0.68 | 4.6% +CA$4.5m | 183.3% | PE-5.4x |